Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients
Med. clín. (Barc); 147 (5), 2016
"BACKGROUND AND OBJECTIVE:
Poor mobilization of peripheral blood stem cells (CD34(+) cells) from bone marrow is a frequent reason for not reaching the autologous stem cell trasplantation (SCT) procedure in patients diagnosed with lymphoma or myeloma. Plerixafor, a reversible inhibitor of the binding of s...
Compuestos Heterocíclicos, Receptores CXCR4, Movilización de Célula Madre Hematopoyética, Compuestos Heterocíclicos, Linfoma, Mieloma Múltiple, Trasplante de Células Madre de Sangre Periférica, Receptores CXCR4/antagonistas & inhibidores, Trasplante Autólogo, Mieloma Múltiple/terapia, Linfoma/terapia